Navigation Links
Ocular Pharma Company Charlesson Announces $2.35MM in New Funding
Date:10/17/2007

Company aims to develop pharmaceutical therapeutics for blinding eye

diseases, including Age-Related Macular Degeneration and Diabetic

Retinopathy

OKLAHOMA CITY, Oct. 17 /PRNewswire/ -- Charlesson, LLC ("Charlesson") today announced that it is the recipient of several Small Business Innovative Research (SBIR) awards from the National Institutes of Health (NIH), and an award from the Oklahoma Center for the Advancement of Science and Technology (OCAST). The four grants total approximately $2,350,000 and will support development of several pharmaceutical drug candidates, as well as nanoparticle-based gene therapies for eye disease.

Mike Moradi, Chief Executive Officer of Charlesson said, "These funds will greatly assist the company in finalizing preclinical studies for an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA). We expect to file our first IND in 2008 and are hopeful that Charlesson's products will improve the quality of life for over 13.3 million Americans suffering from these blinding diseases. We believe these competitive grant awards represent national enthusiasm for our drug development efforts, and Charlesson is now seeking commercial partners for our various compounds", said Mr. Moradi.

Charlesson was awarded $840,000 in a Phase II SBIR award from the NIH to develop CLT-003 for Diabetic Macular Edema (DME). These funds will be used to finalize IND-enabling efficacy and safety data. CLT-003 is a small molecule therapeutic with potent effects on reducing vascular leakage and subsequent neovascularization and inflammation that can occur in the eyes of diabetic patients. Charlesson is also developing efficacy profiles of CLT-003 for treating the "wet" and "dry" forms of Age-Related Macular Degeneration (AMD). "Our preclinical studies have demonstrated that CLT-003 is a safe and potent therapeutic for treating various forms of blinding retinal disea
'/>"/>

SOURCE Charlesson, LLC
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Glaucoma & Ocular Hypertension more likely in patients with refractive errors
2. Metastasis Of Ocular Melanoma To Liver Can Now Be Calculated
3. India to benefit from pharma companies move
4. South Africa Wins landmark case against pharmaceutical giants
5. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
6. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
7. Pharma cos must forge Strategic alliances
8. Jharkhand Pharmacies Refuse To Sell Viagra
9. Setting up a new pharmaceutical industry in India
10. Medicis Pharmaceutical company enters pediatric market
11. Supply of Radiopharmaceuticals Hampered by Attacks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2014)... is a leading review website in the world. It ... announced that GreenGeeks, Arvixe and Hostgator are the best ... http://www.greengeeks.com/cgi-bin/affiliates/clickthru.cgi?id=seohosts ) is one of the best web hosting ... of useful products for sale. On its website, customers ... , As one of the Top 10 Web Hosting ...
(Date:9/1/2014)... Television shows filled with action and sound may be ... cookies, carrots and grapes while watching an excerpt from ... program. , , Television has been blamed for helping ... lifestyle. But the focus of why has been on ... other distracting activities that can cause people to eat ...
(Date:9/1/2014)... News) -- You may be able to convince your brain ... suggests. The study included eight overweight and obese people ... to change how people react to different foods. These participants ... obese people who weren,t in the program. Both groups ... and again six months later. The scans revealed that the ...
(Date:9/1/2014)... (PRWEB) September 01, 2014 An operating ... a hospital for performing surgical operations. An operating room ... tables, surgical booms, operating room lights, imaging displays as ... a report by Transparency Market Research, a U.S.-based market ... to reach USD 4.5 billion by 2019. , ...
(Date:9/1/2014)... Dennis Thompson HealthDay ... An experimental Ebola drug previously given to two American aid ... deadly virus in laboratory tests, researchers report. The drug, ... even if they didn,t get the medication until five days ... of Ebola who were days or even hours away from ...
Breaking Medicine News(10 mins):Health News:The Best Reseller Hosting Suppliers in August Released by Leading Review SiteTop10BestSEOHosting.com 2Health News:Research letter: Viewers ate more while watching Hollywood action flick on TV 2Health News:Train Your Brain to Choose Fruit Salad Over French Fries 2Health News:Operating Room Equipment Market Study 2019 by Transparency Market Research 2Health News:Operating Room Equipment Market Study 2019 by Transparency Market Research 3Health News:Monkey Trial Supports Ebola Drug That May Have Helped 2 Stricken Americans 2Health News:Monkey Trial Supports Ebola Drug That May Have Helped 2 Stricken Americans 3
... to develop the colorectal polyps that can precede colon cancer. ... patients attending for colonoscopy. They found the incidence of polyps// ... cancer - to be greater among current smokers than in ... likely to have more than two polyps, growths greater than ...
... of the antioxidant vitamin E may assist in reducing ... Health Study and the Health Professionals Follow-Up Study', presented by ... Parkinson's disease. The participants have been followed up for several ... ,Those with a high intake of vitamin E ...
... UK inserting a coil into a weakened blood vessel offers ... rate from subarachnoid haemorrhage// - caused by a bursting of ... to 40 per cent in the first 24 hours after ... a clip to prevent further rupture of the blood vessel. ...
... medical centers hope to arbitrate whether a laser can stop ... two forms of macular degeneration, wet and dry. //The dry ... by the formation of yellowish deposits within the layers of ... have a gradual loss of vision. While there are a ...
... researchers of University of Kansas it is observed that poorly ... pain, gas and diarrhea.// Often people suffer from bowel symptoms ... can be found. They have found out that a high ... to digest fructose. ,Found in honey, fruits and ...
... that endometriosis is linked to infertility. There has long ... shows one of the reasons why the disease may ... patients, but concluded that endometriosis causes a certain action ... fluid located near the fallopian tubes. They then studied ...
Cached Medicine News:
(Date:8/29/2014)... Aug. 29, 2014 Research and Markets ... and Development Trend Forecast of Pharmaceutical Equipment Market in ... Research and Development Trend Forecast of Pharmaceutical Equipment ... analyzes China,s pharmaceutical equipment industry ... demand, competition landscape, and business performance of domestic major ...
(Date:8/29/2014)... 2014 According to the ... Services (Equipment, Reagent, Primer, Probe, Custom Oligos), End-User ... Gene Synthesis, NGS, DNA, RNAi) - Global Forecast ... Synthesis Market is expected to reach $1,712.1 Million ... at a CAGR of 9.8% from 2014 to ...
(Date:8/29/2014)... 2014 /PRNewswire-iReach/ -- ChemImage will present a workshop focused ... Zealand Forensic Science Society,s 22 nd International ... Adelaide, Australia .  Forensic Scientists will be ... hyperspectral imaging can bring to examination procedures. ... of Product Development at ChemImage, will host a ...
Breaking Medicine Technology:Research and Development Trend Forecast of Pharmaceutical Equipment Market in China, 2014-2018 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 3Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 4ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 3
This is the second generation of the famous A/O sliding microtome, manufactured in the United States under the Leica trademark....
... base sliding microtome offers the ultimate in ... not least, safety. ,Designed to meet the ... 8000 will also meet the more demanding ... versatility and wide range of accessories will ...
... MNL 440601 Small Sledge Microtome is ideal for ... or skin specimens. Specimen rise is automatic ... 30 microns in increments of 2 microns. ... Stages.,Other Associated Products, Vibratomes Freezing Stages ...
... is a solid solution for setting ... the Vibratome Plus, standard accessory kit, ... mounts w/1/2" head, and a rotating ... of your sectioning needs.,For selection assistance, ...
Medicine Products: